You are the one who chose a grossly inappropriate
Post# of 72440
CTIX can't be compared to any small biotech that I know of, because I know of no other small biotech with 3 drugs in 4 clinical trials in 4 completely different areas of unmet needs, that has been attacked so viciously by shorts that it has a market cap of far less than one start-up biotech with a failed Alzheimer's drug in clinical trials (AXON).
Since you brought up the original flawed comparison, perhaps you can find another such company.